Patents Assigned to JOURNEY1, INC.
-
Patent number: 12044905Abstract: Ophthalmic lenses for correcting refractive error of an eye are disclosed. Ophthalmic lenses include a deformable inner portion and a deformable peripheral portion. When disposed over the optical region of an eye, the inner portion is configured so that engagement of the posterior surface against the eye deforms the posterior surface so that the posterior surface has a shape diverging form the refractive shape of the epithelium when viewing with the eye through the ophthalmic lens. The rigidity of the inner portion is greater than the rigidity of the peripheral portion and the ophthalmic lenses are configured to allow movement relative to the eye upon blinking of the eye and to be substantially centered on the optical region of the cornea following the blinking of the eye. Methods of correcting refractive errors of an eye such as astigmatism or spherical aberration using the ophthalmic lenses are also disclosed.Type: GrantFiled: August 10, 2021Date of Patent: July 23, 2024Assignee: Journey1 IncInventors: Eugene de Juan, Jr., Cary J. Reich, Yair Alster, Matt Clarke, Kuangmon Ashley Tuan, Brian Levy, Raymond Lum, Jose D. Alejandro
-
Patent number: 11126011Abstract: Ophthalmic lenses for correcting refractive error of an eye are disclosed. Ophthalmic lenses include a deformable inner portion and a deformable peripheral portion. When disposed over the optical region of an eye, the inner portion is configured so that engagement of the posterior surface against the eye deforms the posterior surface so that the posterior surface has a shape diverging form the refractive shape of the epithelium when viewing with the eye through the ophthalmic lens. The rigidity of the inner portion is greater than the rigidity of the peripheral portion and the ophthalmic lenses are configured to allow movement relative to the eye upon blinking of the eye and to be substantially centered on the optical region of the cornea following the blinking of the eye. Methods of correcting refractive errors of an eye such as astigmatism or spherical aberration using the ophthalmic lenses are also disclosed.Type: GrantFiled: September 23, 2019Date of Patent: September 21, 2021Assignee: Journey1, Inc.Inventors: Eugene de Juan, Jr., Cary J. Reich, Yair Alster, Matt Clarke, Kuangmon Ashley Tuan, Brian Levy, Raymond Lum, Jose D. Alejandro
-
Patent number: 10663761Abstract: A conformable covering comprises an outer portion with rigidity to resist movement on the cornea and an inner portion to contact the cornea and provide an environment for epithelial regeneration. The inner portion of the covering can be configured in many ways so as to conform at least partially to an ablated stromal surface so as to correct vision. The conformable inner portion may have at least some rigidity so as to smooth the epithelium such that the epithelium regenerates rapidly and is guided with the covering so as to form a smooth layer for vision. The inner portion may comprise an amount of rigidity within a range from about 1×10?4 Pa*m3 to about 5×10?4 Pa*m3 so as to deflect and conform at least partially to the ablated cornea and smooth an inner portion of the ablation with an amount of pressure when deflected.Type: GrantFiled: September 5, 2017Date of Patent: May 26, 2020Assignee: JOURNEY1, INC.Inventors: Eugene De Juan, Jr., Cary J. Reich, Yair Alster, K. Angela MacFarlane, Doug Rimer, Douglas Sutton, Dean Carson, Enrique Barragan, Matt Clarke, Ashley Tuan, Brian Levy
-
Patent number: 10627649Abstract: A conformable covering comprises an outer portion with rigidity to resist movement on the cornea and an inner portion to contact the cornea and provide an environment for epithelial regeneration. The inner portion of the covering can be configured in many ways so as to conform at least partially to an ablated stromal surface so as to correct vision. The conformable inner portion may have at least some rigidity so as to smooth the epithelium such that the epithelium regenerates rapidly and is guided with the covering so as to form a smooth layer for vision. The inner portion may comprise an amount of rigidity within a range from about 1×10?4 Pa*m3 to about 5×10?4 Pa*m3 so as to deflect and conform at least partially to the ablated cornea and smooth an inner portion of the ablation with an amount of pressure when deflected.Type: GrantFiled: October 10, 2016Date of Patent: April 21, 2020Assignee: JOURNEY1, INC.Inventors: Eugene de Juan, Jr., Cary J. Reich, Yair Alster, K. Angela Macfarlane, Doug Rimer, Douglas Sutton, Dean Carson, Enrique Barragan, Matt Clarke, Ashley Tuan, Brian Levy
-
Patent number: 10596038Abstract: Methods and apparatus for the treatment of the eye to reduce pain can treat at least an outer region of the tissue so as to denervate nerves extending into the inner region and reduce the pain. For example, the cornea of the eye may comprise an inner region having an epithelial defect, and an outer portion of the cornea can be treated to reduce pain of the epithelial defect. The outer portion of the cornea can be treated to denervate nerves extending from the outer portion to the inner portion. The outer portion can be treated in many ways to denervate the nerve, for example with one or more of heat, cold or a denervating noxious substance such as capsaicin. The denervation of the nerve can be reversible, such that corneal innervation can return following treatment.Type: GrantFiled: August 23, 2017Date of Patent: March 24, 2020Assignee: JOURNEY1, INC.Inventors: Yair Alster, Hanson S. Gifford, Cary J. Reich, Eugene De Juan, Jr., John A. Scholl, Jose D. Alejandro, Douglas Sutton, Omer Refaeli
-
Patent number: 10555804Abstract: A therapeutic lens for the treatment of an epithelial defect comprises a layer of therapeutic material disposed over the stroma and/or Bowman's membrane to inhibit water flow from the tear liquid to the stroma and/or Bowman's membrane, such that corneal deturgescence can be restored to decrease corneal swelling and light scattering. The layer may cover and protect nerve fibers to decrease pain. The layer may comprise an index of refraction to inhibit light scatter from an anterior surface of the stroma and/or Bowman's membrane. The lens may comprise a curved anterior surface that provides functional vision for the patient when the epithelium regenerates. The layer of therapeutic material can be positioned on the eye in many ways, for example with a spray that is cured to adhere the layer to the exposed surface of the stroma and/or Bowman's membrane.Type: GrantFiled: March 9, 2018Date of Patent: February 11, 2020Assignee: JOURNEY1, INC.Inventors: Eugene De Juan, Jr., Cary J. Reich, Stephen Boyd, Yair Alster, David Sierra, Hanson S. Gifford, Jose D. Alejandro, Richard L. Lindstrom, K. Angela MacFarlane, Douglas Sutton, John Anthony Scholl